Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) Sai Life Sciences has informed that the Board of Directors at their meeting held today, 07 August 2025 have considered and approved that the 26th Annual General Meeting (‘AGM’) of the members of the Company will be held on Thursday, 11 September 2025 at 10:30 AM (IST) through Video Conferencing (VC) / Other Audio-Visual Means (OAVM), in compliance with applicable circulars issued by the Ministry of Corporate Affairs and SEBI. The Notice convening the 26th AGM along with the Annual Report for the financial year 2024–25 will be circulated to the shareholders and submitted to the stock exchanges in due course.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: